Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CLGNNASDAQ:NXLNASDAQ:PTHLNASDAQ:WOK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLGNCollPlant Biotechnologies$1.73+4.8%$2.42$1.55▼$6.33$19.82M1.2411,471 shs13,077 shsNXLNexalin Technology$1.27+2.4%$1.78$0.53▼$4.49$16.93M4.671.25 million shs87,186 shsPTHLPheton Holdings Ltd Class A Ordinary Shares$5.28-1.4%$3.68$1.32▼$6.45$34.72MN/A145,580 shs17,370 shsWOKWORK Medical Technology Group LTD Ordinary Shares$0.52-7.3%$0.50$0.36▼$8.45$7.58MN/A875,341 shs225,046 shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLGNCollPlant Biotechnologies+1.76%-4.95%-30.80%-51.94%-72.93%NXLNexalin Technology+2.42%-1.55%-23.49%-61.63%-6.62%PTHLPheton Holdings Ltd Class A Ordinary Shares-1.40%+20.16%+83.16%+100.57%+527,499,900.00%WOKWORK Medical Technology Group LTD Ordinary Shares-7.25%-7.30%+8.08%-77.23%+51,909,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCLGNCollPlant Biotechnologies2.4427 of 5 stars3.75.00.00.00.00.01.3NXLNexalin Technology2.9196 of 5 stars3.55.00.00.01.43.30.0PTHLPheton Holdings Ltd Class A Ordinary SharesN/AN/AN/AN/AN/AN/AN/AN/AWOKWORK Medical Technology Group LTD Ordinary SharesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLGNCollPlant Biotechnologies 3.33Buy$12.50622.54% UpsideNXLNexalin Technology 3.00Buy$5.00293.70% UpsidePTHLPheton Holdings Ltd Class A Ordinary Shares 0.00N/AN/AN/AWOKWORK Medical Technology Group LTD Ordinary Shares 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest WOK, PTHL, CLGN, and NXL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/27/2025CLGNCollPlant BiotechnologiesD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$14.00 ➝ $14.003/24/2025NXLNexalin TechnologyMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$5.00(Data available from 5/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLGNCollPlant Biotechnologies$515K38.48N/AN/A$2.47 per share0.70NXLNexalin Technology$168.72K100.32N/AN/A$0.43 per share2.95PTHLPheton Holdings Ltd Class A Ordinary Shares$448.20K77.47N/AN/AN/A∞WOKWORK Medical Technology Group LTD Ordinary Shares$11.51M0.66N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLGNCollPlant Biotechnologies-$7.02M-$1.46N/AN/AN/A-2,680.00%-77.05%-61.43%5/27/2025 (Estimated)NXLNexalin Technology-$4.65M-$0.83N/A∞N/A-3,407.98%-187.59%-167.21%N/APTHLPheton Holdings Ltd Class A Ordinary SharesN/AN/A0.00∞N/AN/AN/AN/AN/AWOKWORK Medical Technology Group LTD Ordinary SharesN/AN/A0.00∞N/AN/AN/AN/AN/ALatest WOK, PTHL, CLGN, and NXL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/4/2025Q1 2025CLGNCollPlant Biotechnologies-$0.37N/AN/AN/A$9.76 millionN/A5/13/2025Q1 2025NXLNexalin Technology-$0.10-$0.15-$0.05-$0.15$0.04 million$0.04 million3/26/2025Q4 2024CLGNCollPlant Biotechnologies-$0.42-$0.34+$0.08-$0.34$0.36 million$0.17 million3/14/2025Q4 2024NXLNexalin TechnologyN/A-$0.28N/A-$0.28N/A$0.03 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLGNCollPlant BiotechnologiesN/AN/AN/AN/AN/ANXLNexalin TechnologyN/AN/AN/AN/AN/APTHLPheton Holdings Ltd Class A Ordinary SharesN/AN/AN/AN/AN/AWOKWORK Medical Technology Group LTD Ordinary SharesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLGNCollPlant BiotechnologiesN/A5.385.23NXLNexalin TechnologyN/A16.4215.89PTHLPheton Holdings Ltd Class A Ordinary SharesN/AN/AN/AWOKWORK Medical Technology Group LTD Ordinary SharesN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLGNCollPlant Biotechnologies21.69%NXLNexalin Technology0.65%PTHLPheton Holdings Ltd Class A Ordinary SharesN/AWOKWORK Medical Technology Group LTD Ordinary SharesN/AInsider OwnershipCompanyInsider OwnershipCLGNCollPlant Biotechnologies9.60%NXLNexalin Technology24.00%PTHLPheton Holdings Ltd Class A Ordinary SharesN/AWOKWORK Medical Technology Group LTD Ordinary SharesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLGNCollPlant Biotechnologies7011.46 million10.36 millionOptionableNXLNexalin Technology313.33 million10.11 millionNot OptionablePTHLPheton Holdings Ltd Class A Ordinary Shares116.58 millionN/AN/AWOKWORK Medical Technology Group LTD Ordinary Shares22614.59 millionN/AN/AWOK, PTHL, CLGN, and NXL HeadlinesRecent News About These CompaniesWORK Medical Technology Group LTD Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyApril 11, 2025 | globenewswire.comWORK Medical Technology Group LTD Announces Implementation of Dual-Class Share Structure Effective March 6, 2025March 5, 2025 | globenewswire.comWORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.February 28, 2025 | globenewswire.comWORK Medical Technology Group LTD Reports Financial Results for Fiscal Year 2024February 14, 2025 | prnewswire.comWORK Medical Technology Group LTD's Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024November 27, 2024 | globenewswire.comWORK Medical Technology Group LTD Announces Partial Exercise of Underwriters' Over-Allotment OptionAugust 29, 2024 | globenewswire.comWORK Medical Technology Group LTD Announces Closing of Initial Public OfferingAugust 26, 2024 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesArcher Aviation Gets Analyst Target Upgrade: Time to Load Up?By Jeffrey Neal Johnson | April 25, 2025View Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?Why D-Wave's Project With Davidson Is a Game-Changer For QuantumBy Nathan Reiff | April 30, 2025View Why D-Wave's Project With Davidson Is a Game-Changer For QuantumQualcomm Is 5x Cheaper Than AMD, But Won’t Be for LongBy Sam Quirke | May 13, 2025View Qualcomm Is 5x Cheaper Than AMD, But Won’t Be for LongNVIDIA Stock Surges on Bullish News: How High Could It Climb?By Thomas Hughes | May 13, 2025View NVIDIA Stock Surges on Bullish News: How High Could It Climb?Why Energy Stocks Like Exxon and Hess Are Back in FocusBy Gabriel Osorio-Mazilli | May 4, 2025View Why Energy Stocks Like Exxon and Hess Are Back in FocusWOK, PTHL, CLGN, and NXL Company DescriptionsCollPlant Biotechnologies NASDAQ:CLGN$1.74 +0.09 (+5.15%) As of 05/16/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was founded in 2004 and is headquartered in Rehovot, Israel.Nexalin Technology NASDAQ:NXL$1.27 +0.03 (+2.42%) Closing price 05/16/2025 04:00 PM EasternExtended Trading$1.27 +0.00 (+0.39%) As of 05/16/2025 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.Pheton Holdings Ltd Class A Ordinary Shares NASDAQ:PTHL$5.28 -0.08 (-1.40%) Closing price 05/16/2025 03:57 PM EasternExtended Trading$5.42 +0.15 (+2.75%) As of 05/16/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.WORK Medical Technology Group LTD Ordinary Shares NASDAQ:WOK$0.52 -0.04 (-7.25%) Closing price 05/16/2025 03:58 PM EasternExtended Trading$0.52 0.00 (-0.02%) As of 05/16/2025 06:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.WORK Medical Technology Group Ltd. engages in developing health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/12 - 05/16 Retail Investors Are Betting Big on Rocket Lab—Should You Too? Meta's 5 Key Pillars for AI Growth—Zuckerberg's Bold Vision Taiwan Semiconductor Stock Is The Gift That Keeps on Giving GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine Alibaba's Earnings Just Changed Everything for the Stock Plug Power: Is Q1 Noise An Opportunity for Accumulation? Cisco Stock Eyes New Highs in 2025 on AI, Earnings, Upgrades Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
